EILSF (Fund I) made 8 investments during the period 2007-12. They include a specialty generic injectables company with US FDA approved manufacturing facilities; a US FDA approved manufacturer of specialized medicines for treating Central Nervous System disorders; India’s largest producer of Vitamin D3; India’s largest network of cancer hospitals, and one of India’s Top 3 private ophthalmology networks. It has exited six investments; HCG, Sutures, Gland Pharma and Dr Agarwal’s, Uquifa and Neuland Group. We invite you to learn more about the investments.

India Lifesciences Fund II (Fund-II) has made 11 investments to date. They include one of India’s leading joint replacement hospital chain; a manufacturer of critical care devices; a chain of prosthetic and orthotic clinics; a chain of dermatologist-led aesthetic medicine clinics; a cold chain distribution network engaged in marketing renal and critical care products; a manufacturer of urology consumables and orthopaedic implants, and a fermentation based manufacturer of Vitamin K series of products and probiotics. We invite you to learn more about Fund II investments.